Front > Healthcare, biotech

Healthcare, biotech

Teva  picture: Bloomberg Teva teams with Japan's Otsuka on migraine drug

Otsuka will have exclusive rights in Japan to fremanezumab, which Teva is globally developing in other countries.

CollPlant Bio-Ink Photo: PR CollPlant sets up 3D organ bio-printing unit

The Israeli regenerative medicine company's bio-ink is intended for use in 3D printers that print organs and tissues using various printing technologies.

Twitter Facebook Linkedin RSS Newsletters גלובס Capital  Markets Conference 2017